BridgeMD
New treatment option for Prolonged Mechanical Ventilation
Official title Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
ClinicalTrials.gov ID: NCT07177183
What this study is testing
- What it's testing
- The main objective of the study is to determine whether a subnormal serum creatinine value upon admission to the Post-ICU Care Unit predicts the need for prolonged ventilatory support. A parallel objective of the study is to determine whether exogenous in-take of the dietary supplement creatine in patients with subnormal serum creatinine value is associated with a shortened duration of ventilatory support and improved patients outcome.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients \<18 years of age
- Patients admitted to post-ICU care units at Chronicare Group a.s. in the Czech Republic within 12 months
You likely can't join if
- Patients who are unlikely to be weaned from ventilatory support.
- Patients in palliative care or with a survival probability of \<3 months
- Patients with advanced malignancy
- Patients with a history of chronic kidney disease
- Patients with a history of chronic liver disease
- Patients with supranormal serum creatinine on admission to the post-ICU care unit
See the full eligibility criteria
- Patients \<18 years of age
- Patients admitted to post-ICU care units at Chronicare Group a.s. in the Czech Republic within 12 months
- Patients who are unlikely to be weaned from ventilatory support.
- Patients in palliative care or with a survival probability of \<3 months
- Patients with advanced malignancy
- Patients with a history of chronic kidney disease
- Patients with a history of chronic liver disease
- Patients with supranormal serum creatinine on admission to the post-ICU care unit
- Patients who refused to sign the Informed Consent with participation in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Brno, Czechia
- Milovice, Czechia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brno, Czechia; Milovice, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.